Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase NA 1

Status

Completed 16Active not recruiting 5Terminated 3Recruiting 3Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Conditions

Tobacco Use Disorder 2Tobacco Smoking 1Substance-Related Disorders 1Smoking Cessation 1Cigarette Smoking-Related Carcinoma 1

Interventions

pembrolizumab 551Specimen Handling 465Carboplatin 441Magnetic Resonance Spectroscopy 430Cyclophosphamide 412Cisplatin 397Radiotherapy 313Gemcitabine 309Bevacizumab 307Paclitaxel 294Biopsy 261Drug Therapy 249Capecitabine 242Oxaliplatin 239fludarabine 237Nivolumab 224venetoclax 219Injections 213Docetaxel 205Fluorouracil 203Dexamethasone 187Radiosurgery 172Rituximab 158Pemetrexed 153Standard of Care 146durvalumab 143Leucovorin 139atezolizumab 138toripalimab 134tislelizumab 134

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Interventional × Tobacco Use Cessation Devices × Clear all
NCT05515354 2026-03-19

MC-NRT

Centre for Addiction and Mental Health

Phase 4 Recruiting
1,200 enrolled

Tobacco Smoking, Tobacco Use Disorder, Smoking Cessation, Substance-Related Disorders

NCT07220356 2026-02-02

C-Raven, a Virtual Tobacco Cessation Intervention in Residency Clinics

Johns Hopkins University

Phase 4 Recruiting
30 enrolled

Tobacco Use Disorder

NCT06763536 2025-06-22

ARISE

Ohio State University Comprehensive Cancer Center

Phase NA Recruiting
1,000 enrolled

Cigarette Smoking-Related Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡